Topnav

Archive | Central nervous system

Reducing brain atrophy in MS patients

Merck recently announced the publication of the results of a post hoc analysis of the Phase III CLARITY study in Multiple Sclerosis Journal. The analysis showed that Cladribine Tablets reduced the annualised rate of brain volume loss – also known as brain atrophy – compared with placebo in patients with relapsing remitting multiple sclerosis (RRMS). […]

Continue Reading · 0

Akeso Milnerton launches dedicated adolescent unit

It is estimated that 20% of all adolescents globally suffer from a mental disorder, with suicide being the second leading cause of death among young people worldwide. Common adolescent behavioural disorders including substance abuse, anxiety, depression, trauma and stress-related disorders as well as developing personality problems, are key risk factors contributing to this concerning statistic. […]

Continue Reading · 0

Call for review of mental healthcare service provision

SECTION27 is relieved that the report of Health Ombud, Prof Malegapuru Makgoba, “Circumstances surrounding the deaths of mentally ill patients: Gauteng Province – No Guns: 94+ Silent Deaths and Still Counting” is finally public. We welcome the work the Ombud has done in investigating the deaths. (more…)

Continue Reading · 0

SADAG Tackles Teen Suicide through Teachers

For Teen Suicide Prevention Week, SADAG is training teachers on how to identify teens at risk and intervene to save lives. Suicide touches everyone of all ages, socio-ecocomic groups, races, religions, and gender. The emotional toll on those left behind remains long after the event. Suicide is the leading cause of death in youth aged […]

Continue Reading · 0

Driving with untreated ADHD

Accumulative studies show a strong causal link between increased motor accidents and untreated Attention Deficit Hyperactivity Disorder (ADHD). According to Psychiatrist Dr Rykie Liebenberg, it’s vital for young adults with ADHD to seek proper treatment or they could be at risk on the road. (more…)

Continue Reading · 0

Shifting ADHD perceptions

A new portal, dedicated to understanding and treating Attention Deficit Hyperactivity Disorder (ADHD), as well as dispelling myths around the condition, has been launched in SA. MyADHD is now available for use by patients and healthcare professionals and aims to shift perceptions in the minds of individuals with ADHD – as well as their friends […]

Continue Reading · 0

Antidepressants: Switching and stopping

Neurotransmitters are associated with depression – particularly serotonin, norepinephrine and dopamine. Most antidepressants relieve depression by affecting these neurotransmitters. Each class of antidepressant affects these neurotransmitters in slightly different ways. Selective serotonin reuptake inhibitors (SSRIs). SSRIs include fluoxetine, paroxetine, sertraline, citalopram and escitalopram. Serotonin and norepinephrine reuptake inhibitors (SNRIs). Examples of SNRI medications include duloxetine, […]

Continue Reading · 0